Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001214659-20-001083
Filing Date
2020-02-07
Accepted
2020-02-07 17:12:16
Documents
1
Group Members
MANGROVE PARTNERSNATHANIEL AUGUST

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 p27207sc13ga1.htm SC 13G/A 67064
  Complete submission text file 0001214659-20-001083.txt   68735
Mailing Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080 650-871-0761
CATALYST BIOSCIENCES, INC. (Subject) CIK: 0001124105 (see all company filings)

EIN.: 562020050 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-82442 | Film No.: 20588365
SIC: 2834 Pharmaceutical Preparations

Mailing Address 645 MADISON AVE, 14 FLOOR NEW YORK NY 10022
Business Address MAPLES CORP. SVCS, PO BOX 309 UGLAND HOUSE, S. CHURCH STREET GEORGE TOWN E9 KY1-1104 2128979537
Mangrove Partners Master Fund, Ltd. (Filed by) CIK: 0001569227 (see all company filings)

EIN.: 981083428 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A